12/3/2024

Janusmed amning

Janusmed amning – Zellmine 28

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Etinylestradiol

Etinylestradiol

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Nilsson S, Nygren KG, Johansson ED. Ethinyl estradiol in human milk and plasma after oral administration. Contraception 1978;17(2):131-139.

  2. Croxatto HB, Díaz S, Peralta O, Juez G, Herreros C, Casado ME et al. Fertility regulation in nursing women: IV Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983;27(1):13-25.

  3. Nilsson S, Mellbin T, Hofvander Y, Sundelin C, Valentin J, Nygren KG. Long-term follow-up of children breast-fed by mothers using oral contraceptives. Contraception. 1986;34(5):443-57.

  4. Peralta O, Díaz S, Juez G, Herreros C, Casado ME, Salvatierra AM et al. Fertility regulation in nursing women: V Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth. Contraception. 1983;27(1):27-38.

  5. Madhavapeddi R, Ramachandran P. Side effects of oral contraceptive use in lactating women--enlargement of breast in a breast-fed child. Contraception 1985;32(5):437-443.

  6. Curtis EM. Oral-contraceptive feminization of a normal male infant: report of a case. Obstet Gynecol 1964;23:295-296.

  7. Marriq P, Oddo G. [Letter: Gynecomastia in the newborn induced by maternal milk? An unusual complication of oral contraceptives]. Nouv Presse Med 1974;3(41-43):2579. (Abstrakt)

  8. Kaern T. Effect of an oral contraceptive immediately post partum on initiation of lactation. Br Med J. 1967;3(5566):644-5.

  9. Tankeyoon M, Dusitsin N, Chalapati S, Koetsawang S, Saibiang S, Sas M et al. Effects of hormonal contraceptives on milk volume and infant growth WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception. 1984;30(6):505-22.

  10. Lonnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 1980;33(4):816-824.

  11. FFPRHC Guidance (July 2004): Contraceptive choices for breastfeeding women. J Fam Plann Reprod Health Care 2004;30(3):181-9.

  12. Selected practice recommendations for contraceptive use-3rd ed. (2016). World Health Organization (WHO).

  13. Louise Thunell, Helena Kopp Kallner. Antikonception– bakgrundsdokumentation. Information från Läkemedelsverket 2014;25(2):39

  1. Nilsson S, Nygren KG, Johansson ED. Ethinyl estradiol in human milk and plasma after oral administration. Contraception 1978;17(2):131-139.
  2. Croxatto HB, Díaz S, Peralta O, Juez G, Herreros C, Casado ME et al. Fertility regulation in nursing women: IV Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983;27(1):13-25.
  3. Nilsson S, Mellbin T, Hofvander Y, Sundelin C, Valentin J, Nygren KG. Long-term follow-up of children breast-fed by mothers using oral contraceptives. Contraception. 1986;34(5):443-57.
  4. Peralta O, Díaz S, Juez G, Herreros C, Casado ME, Salvatierra AM et al. Fertility regulation in nursing women: V Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth. Contraception. 1983;27(1):27-38.
  5. Madhavapeddi R, Ramachandran P. Side effects of oral contraceptive use in lactating women--enlargement of breast in a breast-fed child. Contraception 1985;32(5):437-443.
  6. Curtis EM. Oral-contraceptive feminization of a normal male infant: report of a case. Obstet Gynecol 1964;23:295-296.
  7. Marriq P, Oddo G. [Letter: Gynecomastia in the newborn induced by maternal milk? An unusual complication of oral contraceptives]. Nouv Presse Med 1974;3(41-43):2579. (Abstrakt)
  8. Kaern T. Effect of an oral contraceptive immediately post partum on initiation of lactation. Br Med J. 1967;3(5566):644-5.
  9. Tankeyoon M, Dusitsin N, Chalapati S, Koetsawang S, Saibiang S, Sas M et al. Effects of hormonal contraceptives on milk volume and infant growth WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception. 1984;30(6):505-22.
  10. Lonnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 1980;33(4):816-824.
  11. FFPRHC Guidance (July 2004): Contraceptive choices for breastfeeding women. J Fam Plann Reprod Health Care 2004;30(3):181-9.
  12. Selected practice recommendations for contraceptive use-3rd ed. (2016). World Health Organization (WHO).
  13. Louise Thunell, Helena Kopp Kallner. Antikonception– bakgrundsdokumentation. Information från Läkemedelsverket 2014;25(2):39

Innehållet senast uppdaterat 11/7/2024

1 1
1 1

Drospirenon

Drospirenon

Klass : 1

Visa all info

Skriv ut

Kontakta oss

  1. Blode H, Foidart JM, Heithecker R. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women. Eur J Contracept Reprod Health Care 2001;6(3):167-171.

  2. Melka D, Kask K, Colli E, Regidor PA. A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers. Womens Health (Lond). 2020;16(2):1745506520957192.

  3. Regidor PA, Colli E, Jakimiuk A. The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development. Gynecol Endocrinol. 2024;40(1):2382800.

  4. Antikonception-behandlingsrekommendation. Information från Läkemedelsverket. 2014:2;14-28

  5. Selected practice recommendations for contraceptive use-3rd ed. (2016). World Health Organization (WHO).

  1. Blode H, Foidart JM, Heithecker R. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women. Eur J Contracept Reprod Health Care 2001;6(3):167-171.
  2. Melka D, Kask K, Colli E, Regidor PA. A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers. Womens Health (Lond). 2020;16(2):1745506520957192.
  3. Regidor PA, Colli E, Jakimiuk A. The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development. Gynecol Endocrinol. 2024;40(1):2382800.
  4. Antikonception-behandlingsrekommendation. Information från Läkemedelsverket. 2014:2;14-28
  5. Selected practice recommendations for contraceptive use-3rd ed. (2016). World Health Organization (WHO).

Innehållet senast uppdaterat 11/7/2024